# Intra-anal Oxymetazoline in Healthy Adult Volunteers

> **NCT03529487** · PHASE1 · UNKNOWN · sponsor: **RDD Pharma Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Fecal Incontinence

## Interventions

- **DRUG:** Oxymetazoline

## Key facts

- **NCT ID:** NCT03529487
- **Lead sponsor:** RDD Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-20
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-08-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03529487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03529487, "Intra-anal Oxymetazoline in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03529487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*